You have landed on a page of the archived Cochrane Community website. This site is not being maintained or updated.

If you are looking for Cochrane Review evidence, please visit Cochrane’s evidence page.

If you are a Cochrane contributor looking for Community resources, please visit the new Cochrane Community website.

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

Warning: Parameter 2 to onepixelout_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/archive/includes/

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

Phosphodiesterase 4 inhibitors are a new class of oral medicines for treating chronic obstructive pulmonary disease, and the first Cochrane Review was published in May 2011. Jimmy Chong (left), Phillippa Poole (right) and Bonnie Leung from New Zealand, have updated this in November 2013. Jimmy summarises the latest evidence in this podcast.

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]  | Read Review
Updated on: November 11, 2013, 9:09

Comments for improvement or correction are welcome.